A term neonate with early myoclonic encephalopathy caused by RARS2 gene variants: a case report.

作者: Yan Xu , Bing-Bing Wu , Hui-Jun Wang , Shui-Zhen Zhou , Guo-Qiang Cheng

DOI: 10.21037/TP-20-110

关键词:

摘要: The RARS2 gene encodes mitochondrial arginine-tRNA synthetase. Patients with variants of the have pontocerebellar hypoplasia type 6 (PCH6), which is characterized by early onset seizures, progressive microcephaly, and developmental delay. PCH6 a rare encephalopathy. To best our knowledge, seizure ictal video-electroencephalogram (VEEG) was compatible myoclonic encephalopathy (EME) has not been reported. Here we reported term female neonate EME caused heterozygous [NM_020320: exon10: c.773G>A (p. R258H) Maternal, NM_020320: exon4: c.282_285delAGAG Paternal]. Groan first symptom manifested, followed metabolic disorders, marked cerebral atrophy. Metabolic disorders were corrected after feeding extensively hydrolyzed protein formula. Seizures started at 19th day life. Interictal VEEG showed suppression-burst (SB) pattern revealed seizures that (EME). She had frequent resistant to multi-antiepileptic drugs including phenobarbital, levetiracetam oxcarbazepine, soon developed into convulsive status epilepticus. At 7 months age, she severe delay, infantile spasms. Our case report expands phenotypic spectrum PCH6, meanwhile, should be considered causative in patients EME.

参考文章(20)
Vincenzo Belcastro, Mario Barbarini, Salvatore Barca, Isabella Mauro, A novel AMT gene mutation in a newborn with nonketotic hyperglycinemia and early myoclonic encephalopathy. European Journal of Paediatric Neurology. ,vol. 20, pp. 192- 195 ,(2016) , 10.1016/J.EJPN.2015.08.008
Wang-Tso Lee, Disorders of amino acid metabolism associated with epilepsy Brain and Development. ,vol. 33, pp. 745- 752 ,(2011) , 10.1016/J.BRAINDEV.2011.06.014
Zejuan Li, Rhonda Schonberg, Lucia Guidugli, Amy Knight Johnson, Stephen Arnovitz, Sandra Yang, Joseph Scafidi, Marshall L Summar, Gilbert Vezina, Soma Das, Kimberly Chapman, Daniela del Gaudio, A novel mutation in the promoter of RARS2 causes pontocerebellar hypoplasia in two siblings Journal of Human Genetics. ,vol. 60, pp. 363- 369 ,(2015) , 10.1038/JHG.2015.31
Jeanne Hansen, Chelsi Snow, Emily Tuttle, Dalia H Ghoneim, Chun-Song Yang, Adam Spencer, Sonya A Gunter, Christopher D Smyser, Christina A Gurnett, Marwan Shinawi, William B Dobyns, James Wheless, Marc W Halterman, Laura A Jansen, Bryce M Paschal, Alex R Paciorkowski, None, De Novo Mutations in SIK1 Cause a Spectrum of Developmental Epilepsies American Journal of Human Genetics. ,vol. 96, pp. 682- 690 ,(2015) , 10.1016/J.AJHG.2015.02.013
Simon Edvardson, Avraham Shaag, Olga Kolesnikova, John Moshe Gomori, Ivan Tarassov, Tom Einbinder, Ann Saada, Orly Elpeleg, Deleterious Mutation in the Mitochondrial Arginyl-Transfer RNA Synthetase Gene Is Associated with Pontocerebellar Hypoplasia American Journal of Human Genetics. ,vol. 81, pp. 857- 862 ,(2007) , 10.1086/521227
K. Kastrissianakis, G. Anand, G. Quaghebeur, S. Price, P. Prabhakar, J. Marinova, G. Brown, T. McShane, Subdural effusions and lack of early pontocerebellar hypoplasia in siblings with RARS2 mutations Archives of Disease in Childhood. ,vol. 98, pp. 1004- 1007 ,(2013) , 10.1136/ARCHDISCHILD-2013-304308
Shunsuke Ohtahara, Yasuko Yamatogi, Epileptic encephalopathies in early infancy with suppression-burst. Journal of Clinical Neurophysiology. ,vol. 20, pp. 398- 407 ,(2003) , 10.1097/00004691-200311000-00003
Anne Aukett, Michael J. Bennett, Gwilym P. Hosking, Molybdenum Co-factor Deficiency: an Easily Missed Inborn Eror of Metaboism Developmental Medicine & Child Neurology. ,vol. 30, pp. 531- 535 ,(2008) , 10.1111/J.1469-8749.1988.TB04781.X
Liesbeth Backx, Berten Ceulemans, Joris Robert Vermeesch, Koen Devriendt, Hilde Van Esch, Early myoclonic encephalopathy caused by a disruption of the neuregulin-1 receptor ErbB4 European Journal of Human Genetics. ,vol. 17, pp. 378- 382 ,(2009) , 10.1038/EJHG.2008.180